US Stock MarketDetailed Quotes

CARM Carisma Therapeutics

Watchlist
  • 0.485
  • -0.071-12.74%
Trading Dec 12 15:50 ET
20.27MMarket Cap-0.32P/E (TTM)

About Carisma Therapeutics Company

Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors. The company was founded by Michael Klichinsky and Saar Gill in April 2016 and is headquartered in Philadelphia, PA.

Company Profile

SymbolCARM
Company NameCarisma Therapeutics
Listing DateFeb 6, 2014
Founded2016
CEOMr. Steven Kelly
MarketNASDAQ
Employees107
Fiscal Year Ends12-31
Address3675 Market Street,Suite 200
CityPhiladelphia
ProvincePennsylvania
CountryUnited States of America
Zip Code19104
Websitehttp://carismatx.com

Company Executives

  • Name
  • Position
  • Salary
  • Steven Kelly
  • Director, President and Chief Executive Officer
  • 3.50M
  • Richard S. Morris, C.P.A.
  • Chief Financial Officer
  • 1.66M
  • Dr. Michael Klichinsky, PhD,Pharm.D.
  • Chief Scientific Officer
  • 1.60M
  • Sanford S. Zweifach
  • Chairman of the Board
  • 271.55K
  • Sohanya Roshan Cheng, M.B.A.
  • Director
  • --
  • Marella Thorell
  • Director
  • --
  • Dr. David T. Scadden, M.D.
  • Director
  • --
  • Dr. Briggs W. Morrison, M.D.
  • Independent Director
  • 220.20K
  • Dr. John A. Hohneker, M.D.
  • Independent Director
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data